Armanino Foods of Distinction, Inc. (OTCQX: AMNF), a leading international manufacturer of frozen pesto, globally inspired sauces, and filled pasta, today announced its financial results for the ...

Arguably the FDA’s most anticipated decision this month is for a subcutaneous induction formulation of Biogen and Eisai’s ...

DXY made only a three-wave rise from the lows, which indicates for a correction within downtrend. So recovery can basically still be a fourth wave rally, just a bit deeper one that can still belong to ...

Pirtobrutinib had a nominally superior overall response rate compared to ibrutinib in certain patients with chronic ...

Discover the latest advancements in multiple sclerosis (MS) treatment, including innovative therapies and strategies for ...

Soquelitinib data from cohort 3 of atopic dermatitis Phase 1 clinical trial demonstrates earlier and deeper responses compared to cohorts 1-2 along with clinically meaningful reduction in itch as ...

The FDA fast-tracks birelentinib, a dual inhibitor for relapsed CLL/SLL, promising new hope for patients facing treatment ...

BeOne Medicines Ltd (SHSE:688235) reports a 42% revenue surge and strategic advancements, while navigating market pressures and regulatory complexities.

BAKU, Azerbaijan, August 7. Cooperation in the development of the Baku-Tbilisi-Kars (BTK) railway line was discussed during a ...

A key meeting took place in Baku between Rovshan Rustamov, Chairman of Azerbaijan Railways CJSC (ADY), a subsidiary of AZCON ...

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good day, everyone. Welcome to BeOne Q2 2025 Earnings Call Webcast. [Operator Instructions] At this time, I would like to turn the call over ...

Revenue in Q2 2025 increased 38% to $15.56 billion driven by volume growth from Zepbound and Mounjaro. <li /> Increased the midpoint of o ...